Innovation, Research
Therapeutic innovation in the fight against pulmonary arterial hypertension
… and Therapeutic Innovation laboratory (HPPIT - Université Paris-Saclay, Inserm), in collaboration with their … decisive step towards the development of a new treatment to complement reference treatment for the disease. A rare … Despite the combination of vasodilators, half of patients die within seven years of being diagnosed with PAH. A key …
Published on: